Integrating Psychiatry and Medical Biotechnology As A Way To Achieve Scientific,Precision, and Personalized Psychiatry

Besides concerns about the increasing prevalence of psychiatric disorders and the significantburdens and costs, there are concerns about its validity. the dilemma of validitywent so far that studies described the diagnoses in psychiatry as scientificallyworthless. we suggest integrating psychiatry and medical biotechnology and using biotechnologicalproducts in psychiatric aspects help psychiatry become more precise,strengthen its position among other sciences, and increase its scientific credibility bygiving examples. for this matter, we need different inputs to choose between the vastoutputs. the most common inputs are clinical symptoms, cognitive function, individualand environmental risk factors, molecular markers, genetic markers, neuroimagingsigns, and big data. some molecular markers have been shown to have a relationshipwith psychiatric disorders such as interleukin-6 (il-6) and tumor necrosis factor-α(tnf-α). genetic studies might evolve the most accurate part of precision psychiatry.currently, and through the developments in technology, genome-wide associationstudies have become available. in neuroimaging signs, psychiatric disorders are associatedwith generalized rather than focal brain network dysfunction, and functionalmagnetic resonance imaging could be performed to study them. it would exhibit differentaberrancies in various psychiatric disorders. in big data, the constitution of predictivemodels and movement toward precision psychiatry can be led by using artificialintelligence and machine learning.